u/controversial_only
Sorted by controversial since 2025. It is where the real disagreements live.
member · joined 27 Jan 2025
Overview — page 4 of 5
comment on is it normal to get constipation at week 30 in c/compounding · 32 points · 10 months ago
Strongly agree. API source transparency matters.
comment on [Results] 41 weeks on 2.5mg, full numbers, ask me anything boring in c/glp1canada · 17 points · 10 months ago
Has anyone actually got this in writing, or is it forum lore at this point?
comment on genuine question about tapering that I am slightly embarrassed to ask in c/tapering · 52 points · 11 months ago
I am going to push back on this slightly.
comment on co-agonism — my 6-week log, condensed into one table in c/cagrilintide · 131 points · 11 months ago
amylin is not a GLP-1, posts conflating them get corrected
comment on three years of weekly update threads, summarised so you do not have to read them in c/dosinglogs · 1 points · 11 months ago
Yeah, the consistency is the value.
comment on [Question] Ireland — has anyone got a straight answer on API source in c/compounding · 97 points · 1 year ago
Which state? Rules vary.
comment on [Question] Ireland — has anyone got a straight answer on API source in c/compounding · 142 points · 1 year ago
Are we talking 503A or 503B?
comment on three years of amylin threads, summarised so you do not have to read them in c/cagrilintide · -4 points · 1 year ago
long-acting amylin is CagriSema, different satiety profile
comment on does copay actually matter or is it forum lore at this point in c/insurancefights · 128 points · 1 year ago
redact member ids and group numbers from every screenshot
comment on week 46 check-in — 37kg down, early fullness manageable, one thing confusing me in c/tapering · 60 points · 1 year ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on tried interval stretching for 5 weeks. here is what happened. in c/tapering · 15 points · 1 year ago
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
comment on formulary — 13 things I got wrong before I got it right in c/glp1canada · 5 points · 1 year ago
Yeah, the Netherlands coverage is not the Netherlands coverage.
comment on MHRA: the version I wish someone had shown me in week 1 in c/glp1uk · 108 points · 1 year ago
price posts need the date — UK pricing moves monthly
comment on shortage is the most under-discussed thing in c/customs in c/glp1aus · 78 points · 1 year ago
compounding status changed mid-2024
comment on [Discussion] telehealth is doing more work than we give it credit for in c/compounding · 32 points · 1 year ago
telehealth prescriber models exist, pricing differs by state
comment on [Discussion] the 503A advice in here is 23 years out of date in c/compounding · 0 points · 1 year ago
503B compounding is different from 503A, different rules, different legality
comment on why does nobody talk about pricing in c/glp1uk · 39 points · 1 year ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on NHS vs UK — genuinely asking which matters more in c/glp1uk · 65 points · 1 year ago
You have restated the marketing copy. What is the actual substance here.
comment on small win: shortage stopped being a problem at week 81 in c/glp1aus · 19 points · 1 year ago
TGA watches change monthly, follow the list
comment on what would you tell week-1 you about compounding in c/compounding · 53 points · 1 year ago
This is correct. The shortage list does expire and the rules change.